ORATONIN Trademark

Trademark Overview

On Friday, September 4, 2009, a trademark application was filed for ORATONIN with the United States Patent and Trademark Office. The USPTO has given the ORATONIN trademark a serial number of 77820259. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2013. This trademark is owned by Seachaid Pharmaceuticals, Inc.. The ORATONIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation of chemically modified oral calcitonin for the treatment of osteoporosis, osteoarthritis, Paget disease, hypercalcemia, fibromyalgia, osteoporotic fracture pains and bone fracture pains, peripheral and neuropathic pains, obesity, migraine headaches, bone mineral loss, calcinosis, and postmenopausal breast cancer (as an aromatase inhibitor)
oratonin

General Information

Serial Number77820259
Word MarkORATONIN
Filing DateFriday, September 4, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparation of chemically modified oral calcitonin for the treatment of osteoporosis, osteoarthritis, Paget disease, hypercalcemia, fibromyalgia, osteoporotic fracture pains and bone fracture pains, peripheral and neuropathic pains, obesity, migraine headaches, bone mineral loss, calcinosis, and postmenopausal breast cancer (as an aromatase inhibitor)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeachaid Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713
Party NameSeachaid Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Trademark Events

Event DateEvent Description
Tuesday, May 28, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 27, 2013ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 1, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 31, 2012EXTENSION 5 GRANTED
Friday, October 26, 2012EXTENSION 5 FILED
Friday, October 26, 2012TEAS EXTENSION RECEIVED
Wednesday, May 23, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 22, 2012EXTENSION 4 GRANTED
Thursday, April 12, 2012EXTENSION 4 FILED
Thursday, April 12, 2012TEAS EXTENSION RECEIVED
Friday, October 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2011EXTENSION 3 GRANTED
Tuesday, October 11, 2011EXTENSION 3 FILED
Tuesday, October 11, 2011TEAS EXTENSION RECEIVED
Friday, April 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2011EXTENSION 2 GRANTED
Tuesday, April 19, 2011EXTENSION 2 FILED
Tuesday, April 19, 2011TEAS EXTENSION RECEIVED
Tuesday, November 2, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 1, 2010EXTENSION 1 GRANTED
Wednesday, October 13, 2010EXTENSION 1 FILED
Thursday, October 28, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 13, 2010TEAS EXTENSION RECEIVED
Tuesday, April 27, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 2, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2010PUBLISHED FOR OPPOSITION
Monday, December 28, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 28, 2009ASSIGNED TO LIE
Tuesday, December 8, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 8, 2009ASSIGNED TO EXAMINER
Wednesday, September 9, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 8, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

oratonin pains bone fracture headaches mineral migraine obesity neuropathic loss calcinosis